research.solutions.leadership.
The Science
of Health
Explore Dr. Goodenowe’s research, educational videos, live events, and the organizations he has built to advance health at every level—from individuals and professionals to families and communities.
Growing impact
Research connected to people.
Dr. Goodenowe’s work extends from decades of scientific discovery into professional education, practical health programs and direct support for families.
Start here · A message from Dr. Goodenowe
From the laboratory to the community.
In this introduction, Dr. Goodenowe explains how more than 30 years of research led to laboratories, manufacturing, advanced imaging, professional tools, dietary therapeutics and community programs—and how each part contributes to a larger approach to health.
Discover the story behind the organizations, technologies and community initiatives connected through Dr. Goodenowe’s work.
The organizations
Different roles.
A shared purpose.
Explore the organizations carrying Dr. Goodenowe’s work into personal health programs, community initiatives, professional education, research, nutritional technology and therapeutic development.
Perpetual Health
Advanced assessments, personalized programs, education and ongoing support for people pursuing health across a lifetime.
Visit Perpetual Health
Community Health
Community programs expanding access to education, resources and support, including the Moose Jaw Vitality Project and NeuroSupport.
Explore Community Health
03
Elite Practitioner
Advanced education, research-grade tools and professional support for health professionals.
Explore the program
04
Prodrome Sciences
Translating lipid and plasmalogen research into nutritional technologies and biomarker tools.
About Prodrome
05
Dietary Therapeutics
Developing nutrient-based therapeutic candidates through formal clinical and regulatory pathways.
Visit Dietary Therapeutics
06
Dr. Goodenowe Research
Laboratories, biomarker science, advanced imaging, patents, publications and clinical research.
Explore the research
From published research to investigational development.
In 2005, Dr. Goodenowe’s research identified plasmalogen deficiency as a consistent biochemical feature observed in Alzheimer’s disease. The findings were published in the Journal of Lipid Research in 2007 and have since been independently replicated across multiple research groups in Japan, Europe, and North America.
That body of research is the scientific foundation for Dr. Goodenowe Dietary Therapeutics (DGDT), a therapeutic development company currently advancing ProdromeNeuro™ — a plasmalogen precursor compound — through FDA-regulated pathways for the investigation of Alzheimer’s disease and related neurological conditions.
Breaking Alzheimer's
Dr. Goodenowe's account of his research into plasmalogen biochemistry and its observed relationship to neurodegeneration — written for a general audience.
Dr. Goodenowe Dietary Therapeutics
A therapeutic development company advancing plasmalogen-based compounds through FDA-regulated investigational pathways. Lead candidate: ProdromeNeuro™.
Breaking Alzheimer’s (2021) documents the research journey behind this work. ProdromeNeuro™ is an investigational compound. It is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
Our mission is to restore and optimize health by addressing the root causes of disease and enhancing overall well-being.
Our Programs
Biochemical testing, imaging and supplementation for longevity and vitality.
Where Science Supports Care
Medical professionals across disciplines are using Dr. Goodenowe’s tools – from advanced biochemistry testing to targeted protocols – to guide and enhance patient care.